Hyperbranched poly-beta-amino ester polymers condense ribonucleoprotein complexes into nanoparticles.
Biodegradable tail chains in ionizable lipids resolve slow liver metabolism and toxicity trade-offs.
Modified mRNA molecules reduce genomic integration risks and immune responses while improving translation rates.
Short homology arms on linear donors resolve the trade-off between editing efficiency and precision, eliminating selection markers.